Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2017 - 2025)

Historic Goodwill & Intangibles for Dr Reddys Laboratories (RDY) over the last 17 years, with Q3 2025 value amounting to $141.0 million.

  • Dr Reddys Laboratories' Goodwill & Intangibles rose 28.2% to $141.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.0 million, marking a year-over-year increase of 28.2%. This contributed to the annual value of $1.3 billion for FY2025, which is 15748.99% up from last year.
  • As of Q3 2025, Dr Reddys Laboratories' Goodwill & Intangibles stood at $141.0 million, which was up 28.2% from $1.3 billion recorded in Q1 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Goodwill & Intangibles peaked at $1.3 billion during Q1 2025, and registered a low of $51.1 million during Q3 2023.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $424.0 million (2022), whereas its average is $379.6 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Goodwill & Intangibles plummeted by 9010.28% in 2021, and later surged by 17515.14% in 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Goodwill & Intangibles (Quarter) stood at $61.8 million in 2021, then decreased by 12.1% to $54.3 million in 2022, then dropped by 5.89% to $51.1 million in 2023, then surged by 175.15% to $140.6 million in 2024, then grew by 0.28% to $141.0 million in 2025.
  • Its last three reported values are $141.0 million in Q3 2025, $1.3 billion for Q1 2025, and $140.6 million during Q3 2024.